KMDA
$7.37
Kamada
($.03)
(.41%)
KMDA
Earnings Whisper ®
N/A
4th Quarter December 2019
Consensus:  $0.11
Revenue:  $37.66 Mil
Wednesday
Feb 12
7:00 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when KMDA reports earnings?
Beat
Meet
Miss

Where is KMDA's stock price going from here?
Up
Flat
Down
Stock chart of KMDA
Analysts
Summary of analysts' recommendations for KMDA
Score
Grade
Pivots
Resistance
-
-
-

-

Support
-
-
-
Tweet
Growth
Description
Kamada Ltd. is a biopharmaceutical company. It develops, produces and markets therapeutics based on chromatographic purification technology. The company offers bio-therapeutics for specialty proteins, specific immunoglobulins and other prescription medicines. Kamada Ltd. is headquartered in Ness Ziona, Israel.
Peers
BioMarin PharmaceuticalRegeneron PharmaceuticalsInterCeptVertex PharmaceuticalsJohnson & JohnsonZoetisBristol-Myers SquibbEndo International plcMylanUltragenyx Pharmaceutical